Fortrea Holdings (FTRE) Non Operating Income (2022 - 2026)
Fortrea Holdings (FTRE) reported Non Operating Income of $500000.0 for Q1 2026, down 90.2% quarter-over-quarter from $5.1 million in Q3 2025.
Fortrea Holdings (FTRE) Non Operating Income (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Non Operating Income for 5 years, with the latest figure at $500000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income changed N/A year-over-year to $500000.0; the trailing twelve-month figure through Mar 2026 stood at $8.4 million (down 58.0% YoY), and the FY2025 full-year result was $7.9 million, down 62.91% from the prior year.
- Non Operating Income for Q1 2026 stood at $500000.0, down from $5.1 million in the prior quarter.
- The five-year high for Non Operating Income was $9.0 million in Q2 2024, with the low at $400000.0 in Q2 2022.
- Historically, Non Operating Income has averaged $2.7 million across 5 years, with a median of $1.8 million in 2023.
- Annual changes were most pronounced in 2024 — Non Operating Income soared 1700.0% — and 2025, when it sank 68.89%.
- Fortrea Holdings' Non Operating Income stood at $700000.0 in 2022, then surged by 228.57% to $2.3 million in 2023, then jumped by 169.57% to $6.2 million in 2024, then retreated by 17.74% to $5.1 million in 2025, then slumped by 90.2% to $500000.0 in 2026.
- The last three Non Operating Income figures came in at $500000.0 (Q1 2026), $5.1 million (Q3 2025), and $2.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | 500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,000.00 |
| Sep 30, 2025 | 5.10 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Sep 30, 2024 | 4.80 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Sep 30, 2023 | 3.60 Mn |
| Jun 30, 2023 | 500,000.00 |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Sep 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 400,000.00 |